Ownership history in 22NW, LP · 19 quarters on record
This page tracks every 13F SEC filing in which 22NW, LP reported a position in ANEBULO PHARMACEUTICALS INC (ANEB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 15,467,300 | — | 0% | 35.68% | $84.8M | $1.01 |
| 2025 Q3 | UNCHANGED | 15,467,300 | — | 0% | 18.22% | $38.7M | $2.50 |
| 2025 Q2 | UNCHANGED | 15,467,300 | — | 0% | 14.03% | $22.3M | $1.44 |
| 2025 Q1 | UNCHANGED | 15,467,300 | — | 0% | 13.49% | $20.1M | $1.30 |
| 2024 Q4 | ADDED | 15,467,300 | +10,101,010 | +188.2% | 16.39% | $26.0M | $1.68 |
| 2024 Q3 | UNCHANGED | 5,366,290 | — | 0% | 8.68% | $10.4M | $1.93 |
| 2024 Q2 | UNCHANGED | 5,366,290 | — | 0% | 12.50% | $14.6M | $2.73 |
| 2024 Q1 | UNCHANGED | 5,366,290 | — | 0% | 13.27% | $15.4M | $2.87 |
| 2023 Q4 | ADDED | 5,366,290 | +300,000 | +5.9% | 8.46% | $13.0M | $2.42 |
| 2023 Q3 | UNCHANGED | 5,066,290 | — | 0% | 11.03% | $15.5M | $3.06 |
As of 2025 Q4 — sorted by position size